Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lymphoma (Hodgkin).php on line 2
Lymphoma (Hodgkin)
LE WE PMID CA
Lymphoma (Hodgkin)1214Lymphom (Hodgkin)

Arthritis (rheumatoid)

Bacillus calmette guerin

Bartonella henselae

Calcium (Hypercalciemia)

Candida (BASKET)

Coccidioidomycosis

Crohn s disease

Cryptococcosis

Cytokinesis

EBV Epstein barr virus

Fat necrosis subcutaneous of the newborn

Gastrointestinal stromal cell tumor GIST

Histone deacetylase

Histoplasmosis

KLHDC8B

Langerhans cell histiocytosis

Lepra

Liver (Diseases)

Lung (Lipoid pneumonia)

Lung (Toxicology)

Lung and bronchial system (Neoplasia)

Lymphoma (BASKET)

Lymphoma (Hodgkin)

Mycobacterium avium

Neoplasia (Oncofertility)

Neoplasia (Tumor biology and immunology)

Osteoarthritis

Ovary (Neoplasia)

Paracoccoidomycosis

Pneumocystis carinii Pneumocystis jirovicii

Polymyositis

Pseudolymphoma (Lymphomatoid granulomatosis)

Pseudolymphoma (Plasma cell granuloma)

Sarcoidosis

Silicone

Slack skin disease

Testis (Neoplasia Seminoma)

Testis (Neoplasia)

TNFAIP3 A20

Tuberculosis

Twinning

Wegener s granulomatosis

1992  
1
Hodgkin's lymphoma. II: Treatment and delayed morbidity.
[1489407] BMJ 305(6846): 173-6 (1992)
1992  
2
Hodgkin's disease--I: Identification and classification.
[1638255] BMJ 305(6845): 99-102 (1992)
1967  
3
1978  
4
Hodgkin's disease: an overview.
[83007] South Med J 71(12): 1546-52 (1978)
2008  
5
Hodgkin's lymphoma: news from an old disease.
[19075311] Neth J Med 66(11): 457-66 (2008)
2005  
6
An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
[15988816] Yonsei Med J 46(3): 425-30 (2005)
2005  
7
The molecular mechanisms of classic Hodgkin's lymphoma.
[16720015] Yale J Biol Med 78(4): 203-10 (2005)
2008  
8
Treatment of lymphocyte-predominant Hodgkin lymphoma.
[18519402] Ann Oncol 19 Suppl 4(-): iv45-6 (2008)
2008  
9
Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456773] Ann Oncol 19 Suppl 2(-): ii65-6 (2008)
2007  
10
Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.
[17631599] Ann Oncol 18 Suppl 9(-): ix71-9 (2007)
2002  
11
Hodgkin's disease: treatment of relapsed disease.
[12401683] Ann Oncol 13 Suppl 4(-): 159-62 (2002)
2002  
12
Primary treatment of Hodgkin's disease.
[12401682] Ann Oncol 13 Suppl 4(-): 153-8 (2002)
2002  
13
Epidemiology and etiology of Hodgkin's lymphoma.
[12401681] Ann Oncol 13 Suppl 4(-): 147-52 (2002)
2002  
14
Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
[12078913] Ann Oncol 13 Suppl 1(-): 98-101 (2002)
2002  
15
The involved field is back: issues in delineating the radiation field in Hodgkin's disease.
[12078908] Ann Oncol 13 Suppl 1(-): 79-83 (2002)
2002  
16
Late mortality in Hodgkin's disease: can we reduce it?
[12078903] Ann Oncol 13 Suppl 1(-): 5-9 (2002)
2002  
17
1993  
18
2000  
19
Evidence-based management of Hodgkin's disease: the role of autologous stem cell transplantation.
[10832113] Cancer Control 7(3): 266-75 (2000)
2009  
20
Salvage therapy in Hodgkin's lymphoma.
[19342476] Oncologist 14(4): 425-32 (2009)
2007  
21
Salvage therapy in Hodgkin's lymphoma.
[17296811] Oncologist 12(2): 156-67 (2007)
1978  
22
Cultural, morphological, cell membrane, enzymatic, and neoplastic properties of cell lines derived from a Hodgkin's disease lymph node.
[209894] Cancer Res 38(9): 3033-43 (1978)
1978  
23
Observations on cell lines derived from a patient with Hodgkin's disease.
[78764] Cancer Res 38(8): 2581-91 (1978)
1976  
24
Hodgkin's disease and other human malignant lymphomas: advances and prospects--G.H.A. Clowes Memorial Lecture.
[788894] Cancer Res 36(11 Pt 1): 3863-78 (1976)
1971  
25
Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease.
[4941351] Cancer Res 31(11): 1755-67 (1971)
2003  
26
Clinicopathologic and molecular features of Hodgkin's lymphoma.
[14614314] Cancer Biol Ther 2(5): 500-7 (2003)
2000  
27
The molecular and cellular origins of Hodgkin's disease.
[10637266] J Exp Med 191(2): 207-12 (2000)
1994  
28
Controversies in the management of early stage Hodgkin's disease.
[8286731] Blood 83(2): 318-29 (1994)
1970  
29
Hodgkin's disease and other malignant lymphomas.
[4991356] Calif Med 113(4): 23-38 (1970)
1949  
30
Hodgkin's disease; a clinical-pathological review of 150 cases.
[18109362] Calif Med 70(2): 87-92 (1949)
1985  
31
Early-stage Hodgkin's disease: current approaches to treatment.
[3893668] Can Med Assoc J 133(3): 193-8 (1985)
2006  
32
Management of Hodgkin lymphoma.
[16529147] Mayo Clin Proc 81(3): 419-26 (2006)
2005  
33
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.
[15728122] Blood 105(12): 4553-60 (2005)
1999  
34
Problems in Hodgkin's disease management.
[9920825] Blood 93(3): 761-79 (1999)
1994  
35
The cellular biology of the Reed-Sternberg cell.
[8049419] Blood 84(4): 1005-19 (1994)
1981  
36
Hodgkin's disease: biology, treatment, prognosis.
[7011441] Blood 57(5): 813-22 (1981)
2009  
37
Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
[19278966] Haematologica 94(4): 550-65 (2009)
2008  
38
The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells?
[18757849] Haematologica 93(9): 1292-5 (2008)
2005  
39
Current treatment and immunotherapy of Hodgkin's lymphoma.
[16330443] Haematologica 90(12): 1680-92 (2005)
2003  
40
Staging Hodgkin's lymphoma: why and how?
[14555315] Haematologica 88(10): 1176-81 (2003)
2009  
41
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma.
[20008236] Hematology Am Soc Hematol Educ Program -(-): 507-19 (2009)
2009  
42
2007  
43
Risk, cure and complications in advanced hodgkin disease.
[18024630] Hematology Am Soc Hematol Educ Program -(-): 197-203 (2007)
2004  
44
Hodgkin's lymphoma: evolving concepts with implications for practice.
[15561683] Hematology Am Soc Hematol Educ Program -(-): 184-202 (2004)
2003  
45
Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease.
[14633784] Hematology Am Soc Hematol Educ Program -(-): 225-47 (2003)
2001  
46
Hodgkin's lymphoma: basing the treatment on the evidence.
[11722984] Hematology Am Soc Hematol Educ Program -(-): 178-93 (2001)
2001  
47
Extranodal Hodgkin disease: spectrum of disease.
[11158651] Radiographics 21(1): 161-79 (2001)
1988  
48
The contemporary management of Hodgkin disease.
[3140289] Radiology 169(2): 297-304 (1988)
2011  
49
Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.
[21318045] Adv Hematol 2011(-): 439456 (2011)
2011  
50
Hodgkin's Lymphoma: A Review of Neurologic Complications.
[20975772] Adv Hematol 2011(-): 624578 (2011)
2011  
51
Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma.
[20981157] Adv Hematol 2011(-): 258797 (2011)
2006  
52
Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity.
[16284059] Ann Oncol 17(1): 141-5 (2006)
2002  
53
Fertility after treatment for Hodgkin's disease.
[12078896] Ann Oncol 13 Suppl 1(-): 138-47 (2002)
2002  
54
Genetic instability in Hodgkin's lymphoma.
[12078897] Ann Oncol 13 Suppl 1(-): 19-22 (2002)
2002  
55
2010  
56
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555072] Ann Oncol 21 Suppl 5(-): v168-71 (2010)
2010  
57
Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience.
[20332141] Ann Oncol 21(10): 2061-8 (2010)
2009  
58
Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454425] Ann Oncol 20 Suppl 4(-): 108-9 (2009)
2010  
59
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control.
[19901016] Ann Oncol 21(2): 426-8 (2010)
2010  
60
Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)
2007  
61
Treatment of refractory and relapsed Hodgkin's lymphoma: facts and perspectives.
[17229629] Haematologica 92(1): 6-10 (2007)
2010  
62
Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.
[19951972] Haematologica 95(3): 494-500 (2010)
2006  
63
Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.
[17124071] Hematology Am Soc Hematol Educ Program -(-): 266-72 (2006)
2006  
64
The management of patients with limited-stage classical Hodgkin lymphoma.
[17124069] Hematology Am Soc Hematol Educ Program -(-): 253-8 (2006)
2010  
65
Upcoming diagnostic and therapeutic developments in classical Hodgkin's lymphoma.
[21239777] Hematology Am Soc Hematol Educ Program 2010(-): 93-100 (2010)
2008  
66
How is Hodgkin lymphoma in pregnancy best treated? ASH evidence-based review 2008.
[19074052] Hematology Am Soc Hematol Educ Program -(-): 33-4 (2008)
2009  
67
2009  
68
Nodular lymphocyte predominant Hodgkin lymphoma.
[19605845] Oncologist 14(7): 739-51 (2009)
2010  
69
Early-stage Hodgkin's lymphoma.
[20818856] N Engl J Med 363(7): 653-62 (2010)
2005  
70
Current strategies in the treatment of childhood Hodgkins disease.
[16340052] Indian Pediatr 42(11): 1115-28 (2005)
2002  
71
Hodgkin's lymphoma: the pathologist's viewpoint.
[11896065] J Clin Pathol 55(3): 162-76 (2002)
2007  
72
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.
[18042690] J Clin Pathol 60(12): 1342-9 (2007)
2005  
73
Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
[16204683] J Natl Cancer Inst 97(19): 1394-5 (2005)
2009  
74
Role of chemotherapy in Hodgkin's lymphoma.
[19390311] Cancer J 15(2): 150-4 (2009)
2009  
75
Hodgkin lymphoma: an update on its biology with new insights into classification.
[19525189] Clin Lymphoma Myeloma 9(3): 206-16 (2009)
2009  
76
A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
[19380636] J Exp Med 206(5): 977-80 (2009)
2010  
77
KLHDC8B in Hodgkin lymphoma and possibly twinning.
[20585509] Commun Integr Biol 3(2): 154-8 (2010)
2011  
78
Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.
[21133886] Br J Haematol 152(3): 249-60 (2011)
2010  
79
Hodgkin's lymphoma therapy: past, present, and future.
[21050034] Expert Opin Pharmacother 11(17): 2891-906 (2010)
2010  
80
Histone deacetylase inhibitors in Hodgkin lymphoma.
[21127943] Invest New Drugs 28 Suppl 1(): S21-7 (2010)
2010  
81
Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
[21270747] Exp Oncol 32(4): 214-23 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lymphoma (Hodgkin).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lymphoma (Hodgkin).php on line 92